Description
Product Description: Elbonix is an orally bioavailable, small-molecule TPO-receptor agonist that interacts with the transmembrane domain of the human TPO-receptor and initiates signaling cascades that induce proliferation and differentiation from bone marrow progenitor cells. Elbonix is available in tablet form for oral administration.
Product Features:
- Improves chronic ITP & SAA effectively
- Effective in chronic hepatitis C-related thrombocytopenia
- Increases & maintains platelet counts
| Product Name | : Elbonix |
| Generic Name | : Eltrombopag Olamine |
| Formulation | : Tablet |
| Available Pack Size | : 4×7 ’s and 4×7’s |
| Available Strengths | : 25 mg and 50 mg |
| Registrations | : Bangladesh |
| Category | : Hematopoietic |
Reviews
There are no reviews yet.